EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline

Jon Rodríguez-Antigüedad, Saül Martínez-Horta, Arnau Puig-Davi, Andrea Horta-Barba, Javier Pagonabarraga, Teresa de Deus Fonticoba, Silvia Jesús, Marina Cosgaya, Juan García Caldentey, María Asunción Ávila-Rivera, Nuria Caballol, Inés Legarda und 31 weitere

Journal of Neurology · 2025-03 · 272 (3)

DOI: 10.1007/s00415-024-12808-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurology, online erschienen am 05.03.2025. Verfasst von Jon Rodríguez-Antigüedad und 42 weiteren Autor:innen. Beteiligte Einrichtung: Medicine Department, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundación Científica Asociación Española Contra el Cáncer, Alpha Bioresearch, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson’s Disease (PD)-associated subjective cognitive decline (PDSCD) is defined as cognitive complaints without objective cognitive impairment. Based on most studies, it is associated with a greater risk of cognitive decline and may represent a prodromal stage of cognitive impairment.

Methods

The main objectives are to identify cognitive progression patterns and clinical predictors of worse cognitive decline within a large PD-SCD cohort with a 4-year followup. All patients belong to the prospective observational multicenter study COPPADIS.

Results

A total of 198 PD-SCD subjects were analyzed. Mean age was 60.9, mean disease duration 5.2, and mean PD-Cognitive Rating Scale (PD-CRS) 97.6. Subjects were classified as Progressors if their Reliable Change Index was ≤ − 1.64 at year 4, and as non-Progressors if it was > − 1.64 (− 1.64 corresponded to − 16 on the PD-CRS). Progressors had significantly higher age, Movement Disorders Society-Unified PD Rating Scale (MDS-UPDRS) III, levodopa equivalent daily-dose, Non-Motor Symptom Scale total score, memory-related cognitive complaints, and prevalence of REM-sleep behavior disorder (RBD) at baseline. A linear mixed-effects model showed divergent cognitive trajectories between Progressors and non-Progressors (estimate = − 26.8; p < 0.001), with no differences in motor trajectories. In the binary regression model, age (OR = 1.09; p = 0.001), MDS-UPDRS III (OR = 1.05, p = 0.008), and RBD (OR = 2.55, p = 0.010) at baseline were independent predictors of cognitive progression.

Conclusions

Subjects with PD-SCD do not consistently show cognitive decline, but rather exhibit a heterogeneous progression. Age, MDS-UPDRS III and RBD significantly increase the risk of a more aggressive cognitive phenotype. Future research on biomarkers will help explore additional cognitive predictors in PD-SCD.

Schlagwörter

Stichwörter der Autor:innen

Cognitive complaintsCognitive declinePD-Subjective Cognitive DeclineParkinson’s DiseaseREM-sleep behavior disorder

Autor:innen und Institutionen

  • Medicine Department, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Movement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Mas Casanovas 90, 08041, Barcelona, Spain.
  • Institut d´Investigacions Biomèdiques-Sant Pau (IIB-Sant Pau), Barcelona, Spain.
  • Centro de Investigación Biomédica en Red-Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
  • Neurology Department, Complejo Hospitalario Universitario de Ferrol (CHUF), A Coruña, Spain.
  • Movement Disorders Unit, Neurology and Clinical Neurophysiology Department, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC, Universidad de Sevilla, Seville, Spain.

Förderung

  • Fundación Científica Asociación Española Contra el Cáncer
  • Alpha Bioresearch
  • Instituto de Salud Carlos III
  • Universitat Autònoma de Barcelona

Zitieren

APA

Rodríguez-Antigüedad, J., Martínez-Horta, S., Puig-Davi, A., Horta-Barba, A., Pagonabarraga, J., de Deus Fonticoba, T., Jesús, S., Cosgaya, M., García Caldentey, J., Ávila-Rivera, M. A., Caballol, N., Legarda, I., Hernández Vara, J., Cabo, I., López Manzanares, L., González Aramburu, I., Gómez Mayordomo, V., González Ardura, J., Dotor García-Soto, J., …, & Kulisevsky, J. (2025). Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline. Journal of Neurology, 272(3). https://doi.org/10.1007/s00415-024-12808-0

Vancouver

Rodríguez-Antigüedad J, Martínez-Horta S, Puig-Davi A, Horta-Barba A, Pagonabarraga J, de Deus Fonticoba T, et al. Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline. Journal of Neurology. 2025;272(3). doi:10.1007/s00415-024-12808-0

BibTeX
@article{RodrguezAntigedad2025,
  author = {Rodríguez-Antigüedad, Jon and Martínez-Horta, Saül and Puig-Davi, Arnau and Horta-Barba, Andrea and Pagonabarraga, Javier and de Deus Fonticoba, Teresa and Jesús, Silvia and Cosgaya, Marina and García Caldentey, Juan and Ávila-Rivera, María Asunción and Caballol, Nuria and Legarda, Inés and Hernández Vara, Jorge and Cabo, Iria and López Manzanares, Lydia and González Aramburu, Isabel and Gómez Mayordomo, Víctor and González Ardura, Jessica and Dotor García-Soto, Julio and Borrué, Carmen and Solano Vila, Berta and Álvarez Sauco, María and Vela, Lydia and Escalante, Sonia and Cubo, Esther and Mendoza, Zebenzui and Pareés, Isabel and Sánchez Alonso, Pilar and Alonso Losada, María G and López Ariztegui, Nuria and Gastón, Itziar and Ruíz Martínez, Javier and Buongiorno, María Teresa and Ordás, Carlos and Valero, Caridad and Puente, Víctor and Kurtis, Mónica and Blázquez Estrada, Marta and Martínez-Martín, Pablo and Mir, Pablo and Santos-García, Diego and COPPADIS Study Group, COPPADIS Study Group and Kulisevsky, Jaime},
  title = {Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline},
  journal = {Journal of Neurology},
  year = {2025},
  volume = {272},
  number = {3},
  doi = {10.1007/s00415-024-12808-0}
}
Kostenlos starten →